Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines

Cancer Biotherapy & Radiopharmaceuticals Sep 2017, Vol. 32, No. 7: 229-238.


http://ift.tt/2eZAU2m